<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined the extent of extracranial carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> as evaluated by a B-mode ultrasound score in four groups of hospitalized patients: hospital controls free of both cerebrovascular symptoms and <z:hpo ids='HP_0004929'>coronary atherosclerosis</z:hpo> (HC, n = 245); patients with <z:hpo ids='HP_0004929'>coronary atherosclerosis</z:hpo> but without cerebrovascular symptoms (CAD, n = 382); patients with <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> but asymptomatic for <z:hpo ids='HP_0004929'>coronary atherosclerosis</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>, n = 107); and patients having both <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> and symptomatic coronary events (<z:hpo ids='HP_0002326'>TIA</z:hpo> + CAD, n = 39) </plain></SENT>
<SENT sid="1" pm="."><plain>The unadjusted B-mode scores were lowest for the HC group, intermediate for the CAD group, and highest for the <z:hpo ids='HP_0002326'>TIA</z:hpo> or <z:hpo ids='HP_0002326'>TIA</z:hpo> + CAD groups (no difference between these two groups) </plain></SENT>
<SENT sid="2" pm="."><plain>However, after adjustment for age (or age and other risk factors), we could find no significant differences among the CAD, <z:hpo ids='HP_0002326'>TIA</z:hpo>, and <z:hpo ids='HP_0002326'>TIA</z:hpo> + CAD groups, while the HC group had significantly lower adjusted scores </plain></SENT>
<SENT sid="3" pm="."><plain>These data suggest that 1) accentuated development of carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> is associated with both <z:hpo ids='HP_0002326'>TIA</z:hpo> and CAD and 2) the apparent differences in extracranial carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> between coronary and cerebrovascular patients are partly attributable to differences in risk factor profiles (most notably age) </plain></SENT>
<SENT sid="4" pm="."><plain>The potentially accentuated rate of development of extracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in patients with CAD mandates a low threshold for cerebrovascular evaluation in CAD patients </plain></SENT>
</text></document>